The emerging approach of this peptide represents a major development in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects dual pathways – GLP-1 and GIP – leading to https://tirzepatide-peptide384744.madmouseblog.com/22766740/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment